# Abaloparatide vs other drugs for osteoporosis in men

Source: https://pepvault.app/research/abaloparatide-chen-2025

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Abaloparatide](https://pepvault.app/research#abaloparatide)

Meta-analysis · people

# Abaloparatide, teriparatide beat other drugs on spine BMD in men

Checked against the paper November 2026 Meta-analysis [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In men with osteoporosis, abaloparatide was among the top options for spine and femoral neck bone density, but it did not lead on total hip density or on side effects.

- **Kind:** Meta-analysis
- **Studied in:** People
- **Published:** 2025
- **Journal:** Front Endocrinol (Lausanne)

## What they tested

The team wanted to compare how well and how safely five drug options treat osteoporosis in men: abaloparatide, denosumab, teriparatide, oral bisphosphonates and intravenous (IV) bisphosphonates.

## How the study was done

A systematic review and Bayesian network meta-analysis, a method that pools published studies to compare several treatments at once, focused on men with osteoporosis. It compared the five drug options on bone mineral density (BMD, a measure of how dense bones are) and on adverse events (side effects).

<!--promo-->

PepVault for iPhone

## Taking abaloparatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

Abaloparatide and teriparatide did significantly better than the other drugs for raising BMD at the lumbar spine (lower back) and the femoral neck (the top of the thigh bone near the hip joint). Oral bisphosphonates did best for total hip BMD, where teriparatide did less well. On safety, teriparatide did best for all adverse events, and oral bisphosphonates did best for lowering severe adverse events.

## What it doesn’t show

This study covers men only. It compares the drugs by pooling separate studies rather than testing them side by side in a single trial.

## The paper

Chen et al. Efficacy and safety of abaloparatide, denosumab, teriparatide, oral bisphosphonates, and intravenous bisphosphonates in the treatment of male osteoporosis: a systematic review and Bayesian network meta-analysis. Front Endocrinol (Lausanne). 2025.

- [PubMed (PMID 40309441)](https://pubmed.ncbi.nlm.nih.gov/40309441/)
- [The paper (DOI 10.3389/fendo.2025.1558560)](https://doi.org/10.3389/fendo.2025.1558560)

## The compounds

- [Abaloparatide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/abaloparatide)
- [Teriparatide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/teriparatide)
- [Abaloparatide dose guide](https://pepvault.app/lab/dosage/abaloparatide)
- [Teriparatide dose guide](https://pepvault.app/lab/dosage/teriparatide)

## With this study

### Abaloparatide

- [Abaloparatide: the full reference](https://pepvault.app/peptides/abaloparatide)
- [Abaloparatide dose guide](https://pepvault.app/lab/dosage/abaloparatide)

### Teriparatide

- [Teriparatide: the full reference](https://pepvault.app/peptides/teriparatide)
- [Teriparatide dose guide](https://pepvault.app/lab/dosage/teriparatide)

### Studies

- [Abaloparatide: larger hip BMD gains than teriparatide at 24 weeks](https://pepvault.app/research/abaloparatide-hong-2023)
- [Abaloparatide raised hip BMD around a virtual hip stem in ACTIVE](https://pepvault.app/research/abaloparatide-active-2024)
- [All 8 studies](https://pepvault.app/research#abaloparatide)
- [Teriparatide cut fracture risk vs bisphosphonates (RR 0.61)](https://pepvault.app/research/teriparatide-li-2024)
- [All 10 studies](https://pepvault.app/research#teriparatide)

### Compared with

- [Teriparatide vs Abaloparatide](https://pepvault.app/peptides/compare/teriparatide-vs-abaloparatide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Meta-analysis](https://pepvault.app/glossary/meta-analysis)
- [Bone mineral density (BMD)](https://pepvault.app/glossary/bone-mineral-density)

## More studies on Abaloparatide

- [Abaloparatide: larger hip BMD gains than teriparatide at 24 weeks](https://pepvault.app/research/abaloparatide-hong-2023) Meta-analysis · people · 2023
- [Abaloparatide raised hip BMD around a virtual hip stem in ACTIVE](https://pepvault.app/research/abaloparatide-active-2024) Randomized trial · people · 2024
- [Abaloparatide improved hip geometry vs placebo in ACTIVE-J](https://pepvault.app/research/abaloparatide-active-j-2023) Randomized trial · people · 2023
- [Abaloparatide then alendronate: 84% lower vertebral fracture risk](https://pepvault.app/research/abaloparatide-activextend-2018) Randomized trial · people · 2018
- [Abaloparatide: normal bone biopsies after up to 18 months in ACTIVE](https://pepvault.app/research/abaloparatide-active-2017) Randomized trial · people · 2017
- [Abaloparatide: fewer new vertebral fractures vs placebo in ACTIVE](https://pepvault.app/research/abaloparatide-active-2016) Randomized trial · people · 2016
- [Every study on Abaloparatide](https://pepvault.app/research#abaloparatide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking abaloparatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking abaloparatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Abaloparatide

- [Abaloparatide: the full reference](https://pepvault.app/peptides/abaloparatide)
- [Abaloparatide dose guide](https://pepvault.app/lab/dosage/abaloparatide)

### Teriparatide

- [Teriparatide: the full reference](https://pepvault.app/peptides/teriparatide)
- [Teriparatide dose guide](https://pepvault.app/lab/dosage/teriparatide)

### Studies

- [Abaloparatide: larger hip BMD gains than teriparatide at 24 weeks](https://pepvault.app/research/abaloparatide-hong-2023)
- [Abaloparatide raised hip BMD around a virtual hip stem in ACTIVE](https://pepvault.app/research/abaloparatide-active-2024)
- [All 8 studies](https://pepvault.app/research#abaloparatide)
- [Teriparatide cut fracture risk vs bisphosphonates (RR 0.61)](https://pepvault.app/research/teriparatide-li-2024)
- [All 10 studies](https://pepvault.app/research#teriparatide)

### Compared with

- [Teriparatide vs Abaloparatide](https://pepvault.app/peptides/compare/teriparatide-vs-abaloparatide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Meta-analysis](https://pepvault.app/glossary/meta-analysis)
- [Bone mineral density (BMD)](https://pepvault.app/glossary/bone-mineral-density)

<!--promo-->

PepVault for iPhone

## Taking abaloparatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Abaloparatide](https://pepvault.app/research#abaloparatide)

## The library

- [Abaloparatide](https://pepvault.app/peptides/abaloparatide)
- [Abaloparatide dose guide](https://pepvault.app/lab/dosage/abaloparatide)
- [Teriparatide](https://pepvault.app/peptides/teriparatide)
- [Teriparatide dose guide](https://pepvault.app/lab/dosage/teriparatide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
